Answers are grounded in this paper and cite their sources.
Objective. There are different diagnostic criteria for the diagnosis of Allergic bronchopulmonary aspergillosis (ABPA) in CF patients. In this present study we evaluated the prevalence of ABPA in Iranian CF patients by two more usual diagnostic criteria as ISHAM working criteria (A) and CF Foundation Consensus Conference criteria (B). Methods. Eighty-six CF patients were included in the study. All CF patients underwent for Aspergillus skin prick test (AST), Aspergillus-specific IgE (sIgEAf ) and Aspergillus-specific IgG (sIgGAf ), total IgE. The ABPA prevalence was estimated by two diagnostic criteria, (A) and (B) and compared. Results. The frequency of positive AST, total IgE, sIgEAf and sIgGAf were 47 (54.6%), 9 (10.5%), 42 (48.8%) and 67 (77.9%), respectively. The obtained rate of ABPA prevalence (10.5%) was identical in two diagnostic criteria A and B (kappa value of 1.000). Conclusions. The applied diagnostic criteria had no significant effect on the reported rate of ABPA prevalence. a different type of disease ranged from allergic reactions to life threatening invasive infections. Allergic bronchopulmonary aspergillosis (ABPA) is an immunological disorder caused by a hypersensitivity reaction to Aspergillus species allergens especially A. fumigatus. ABPA is a frequent event in patients with asthma and CF (3). The estimated ABPA prevalence in patients with CF was reported to be from 3% to 25% in adult patients, and 8% to 10% in children, with an overall prevalence of 8.9% (4,5).
No takes yet. Share an insight, caveat, or question.
Maleki et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: